The DOI matches its Crossref record; 132 of the 132 references it cites were found in a registry or an index.
The Molecular and Genetic Basis of Neurological Tumours
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Vogelstein, B., Lane, D., & Levine, A. J. (2000) · Nature · doi:10.1038/35042675 · Cited by 6,607 · cited 1×
“cgi?l=7157">p53 tumour suppressor — a transcription factor that regulates cell-cycle progression and apoptosis in response to many external insults (such as DNA damage and oncogenic mutations”
Backgroundras oncogenes in human cancer: a review.
Bos, J. L. (1989) · PubMed · Cited by 5,061
Lessons from hereditary colorectal cancer
Kinzler, K. W., & Vogelstein, B. (1996) · Cell · doi:10.1016/s0092-8674(00)81333-1 · Cited by 4,919
Gage, F. H. (2000) · Science · doi:10.1126/science.287.5457.1433 · Cited by 4,786
Li, J., Yen, C., Liaw, D., Podsypanina, K., Bose, S., Wang, S. I., Puc, J., Miliaresis, C., Rodgers, L., McCombie, R., et al. (1997) · Science · doi:10.1126/science.275.5308.1943 · Cited by 4,785
Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours
Donehower, L. A., Harvey, M., Slagle, B. L., McArthur, M. J., Montgomery, C. A., Butel, J. S., & Bradley, A. (1992) · Nature · doi:10.1038/356215a0 · Cited by 4,649
Reynolds, B. A., & Weiss, S. (1992) · Science · doi:10.1126/science.1553558 · Cited by 4,482
Subventricular zone astrocytes are neural stem cells in the adult mammalian brain
Doetsch, F., Caillé, I., Lim, D. A., García-Verdugo, J. M., & Alvarez-Buylla, A. (1999) · Cell · doi:10.1016/s0092-8674(00)80783-7 · Cited by 3,898
Germ Line p53 Mutations in a Familial Syndrome of Breast Cancer, Sarcomas, and Other Neoplasms
Malkin, D., Li, F. P., Strong, L. C., Fraumeni, J. F., Nelson, C. E., Kim, D. H., Kassel, J., Gryka, M. A., Bischoff, F. Z., Tainsky, M. A., et al. (1990) · Science · doi:10.1126/science.1978757 · Cited by 3,765
Maehama, T., & Dixon, J. E. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.22.13375 · Cited by 3,104
Steck, P. A., Pershouse, M. A., Jasser, S. A., Yung, W. K. A., Lin, H., Ligon, A. H., Langford, L. A., Baumgard, M. L., Hattier, T., Davis, T., et al. (1997) · Nature Genetics · doi:10.1038/ng0497-356 · Cited by 2,741
Hunter, T. (2000) · Cell · doi:10.1016/s0092-8674(00)81688-8 · Cited by 2,586
Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN
Stambolic, V., Suzuki, A., de la Pompa, J. L., Brothers, G. M., Mirtsos, C., Sasaki, T., Ruland, J., Penninger, J. M., Siderovski, D. P., & Mak, T. W. (1998) · Cell · doi:10.1016/s0092-8674(00)81780-8 · Cited by 2,551
Prediction of central nervous system embryonal tumour outcome based on gene expression
Pomeroy, S. L., Tamayo, P., Gaasenbeek, M., Sturla, L. M., Angelo, M., McLaughlin, M. E., Kim, J. Y. H., Goumnerova, L. C., Black, P. M., Lau, C., et al. (2002) · Nature · doi:10.1038/415436a · Cited by 2,371
Tumor spectrum analysis in p53-mutant mice
Jacks, T., Remington, L., Williams, B. O., Schmitt, E. M., Halachmi, S., Bronson, R. T., & Weinberg, R. A. (1994) · Current Biology · doi:10.1016/s0960-9822(00)00002-6 · Cited by 2,051
Neurons derived from radial glial cells establish radial units in neocortex
Noctor, S. C., Flint, A. C., Weissman, T. A., Dammerman, R. S., & Kriegstein, A. R. (2001) · Nature · doi:10.1038/35055553 · Cited by 2,016
An Adenovirus Mutant That Replicates Selectively in p53- Deficient Human Tumor Cells
Bischoff, J. R., Kirn, D. H., Williams, A., Heise, C., Horn, S., Muna, M., Ng, L., Nye, J. A., Sampson-Johannes, A., Fattaey, A., et al. (1996) · Science · doi:10.1126/science.274.5286.373 · Cited by 1,760
Role of the INK4a Locus in Tumor Suppression and Cell Mortality
Serrano, M., Lee, H.-W., Chin, L., Cordon-Cardo, C., Beach, D., & DePinho, R. A. (1996) · Cell · doi:10.1016/s0092-8674(00)81079-x · Cited by 1,585
A multipotent EGF-responsive striatal embryonic progenitor cell produces neurons and astrocytes
Reynolds, B., Tetzlaff, W., & Weiss, S. (1992) · The Journal of Neuroscience · doi:10.1523/jneurosci.12-11-04565.1992 · Cited by 1,509
Astrocytes give rise to new neurons in the adult mammalian hippocampus
Seri, B., Garcı́a-Verdugo, J. M., McEwen, B. S., & Alvarez-Buylla, A. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-18-07153.2001 · Cited by 1,495
The development of neural stem cells
Temple, S. (2001) · Nature · doi:10.1038/35102174 · Cited by 1,491
To cycle or not to cycle: a critical decision in cancer
Malumbres, M., & Barbacid, M. (2001) · Nature Reviews Cancer · doi:10.1038/35106065 · Cited by 1,468
Malignant glioma: genetics and biology of a grave matter
Maher, E. A., Furnari, F. B., Bachoo, R. M., Rowitch, D. H., Louis, D. N., Cavenee, W. K., & DePinho, R. A. (2001) · Genes & Development · doi:10.1101/gad.891601 · Cited by 1,229
Inhibition of cell migration, spreading, and focal adhesions by tumor suppressor PTEN
Tamura, M., Gu, J., Matsumoto, K., Aota, S.-I., Parsons, R., & Yamada, K. M. (1998) · Science · doi:10.1126/science.280.5369.1614 · Cited by 1,215
Germ-line transmission of a mutated p53 gene in a cancer-prone family with Li–Fraumeni syndrome
Srivastava, S., Zou, Z., Pirollo, K., Blattner, W., & Chang, E. H. (1990) · Nature · doi:10.1038/348747a0 · Cited by 1,211
The lipid phosphatase activity of PTEN is critical for its tumor supressor function
Myers, M. P., Pass, I., Batty, I. H., Van der Kaay, J., Stolarov, J. P., Hemmings, B. A., Wigler, M. H., Downes, C. P., & Tonks, N. K. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.23.13513 · Cited by 1,168
Isolation of radial glial cells by fluorescent-activated cell sorting reveals a neuronal lineage
Malatesta, P., Hartfuss, E., & Götz, M. (2000) · Development · doi:10.1242/dev.127.24.5253 · Cited by 1,157
Lu, Q. R., Sun, T., Zhu, Z., Ma, N., Garcia, M., Stiles, C. D., & Rowitch, D. H. (2002) · Cell · doi:10.1016/s0092-8674(02)00678-5 · Cited by 1,073
The bHLH Transcription Factors OLIG2 and OLIG1 Couple Neuronal and Glial Subtype Specification
Zhou, Q., & Anderson, D. J. (2002) · Cell · doi:10.1016/s0092-8674(02)00677-3 · Cited by 1,059
A unified hypothesis on the lineage of neural stem cells
Alvarez-Buylla, A., García-Verdugo, J. M., & Tramontin, A. D. (2001) · Nature Reviews Neuroscience · doi:10.1038/35067582 · Cited by 996
The INK4a/ARF network in tumour suppression
Sherr, C. J. (2001) · Nature Reviews Molecular Cell Biology · doi:10.1038/35096061 · Cited by 996
A mutant epidermal growth factor receptor common in human glioma confers enhanced tumorigenicity.
Nishikawa, R., Ji, X. D., Harmon, R. C., Lazar, C. S., Gill, G. N., Cavenee, W. K., & Huang, H. J. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.16.7727 · Cited by 936
Marino, S., Vooijs, M., van der Gulden, H., Jonkers, J., & Berns, A. (2000) · Genes & Development · doi:10.1101/gad.14.8.994 · Cited by 920
Combined activation of Ras and Akt in neural progenitors induces glioblastoma formation in mice
Holland, E. C., Celestino, J., Dai, C., Schaefer, L., Sawaya, R. E., & Fuller, G. N. (2000) · Nature Genetics · doi:10.1038/75596 · Cited by 905
Neurofibromatosis, Phenotype, Natural History, and Pathogenesis
Riccardi, V. M., & Smirniotopoulos, J. (1992) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199211000-00009 · Cited by 893
Oligodendrocyte Precursor Cells Reprogrammed to Become Multipotential CNS Stem Cells
Kondo, T., & Raff, M. (2000) · Science · doi:10.1126/science.289.5485.1754 · Cited by 878
Li, D., & Sun, H. (1997) · PubMed · Cited by 866
Loss of p16Ink4a with retention of p19Arf predisposes mice to tumorigenesis
Sharpless, N. E., Bardeesy, N., Lee, K.-H., Carrasco, D., Castrillon, D. H., Aguirre, A. J., Wu, E. A., Horner, J. W., & DePinho, R. A. (2001) · Nature · doi:10.1038/35092592 · Cited by 848
Groszer, M., Erickson, R., Scripture-Adams, D. D., Lesche, R., Trumpp, A., Zack, J. A., Kornblum, H. I., Liu, X., & Wu, H. (2001) · Science · doi:10.1126/science.1065518 · Cited by 798
Tumour predisposition in mice heterozygous for a targeted mutation in Nf1
Jacks, T., Shih, T. S., Schmitt, E. M., Bronson, R. T., Bernards, A., & Weinberg, R. A. (1994) · Nature Genetics · doi:10.1038/ng0794-353 · Cited by 778
P-TEN, the tumor suppressor from human chromosome 10q23, is a dual-specificity phosphatase
Myers, M. P., Stolarov, J. P., Eng, C., Li, J., Wang, S. I., Wigler, M. H., Parsons, R., & Tonks, N. K. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.17.9052 · Cited by 775
Characterization of CNS Precursor Subtypes and Radial Glia
Hartfuss, E., Galli, R., Heins, N., & Götz, M. (2001) · Developmental Biology · doi:10.1006/dbio.2000.9962 · Cited by 753
Morrison, S. J., White, P. M., Zock, C., & Anderson, D. J. (1999) · Cell · doi:10.1016/s0092-8674(00)80583-8 · Cited by 750
Glial Cell Diversification in the Rat Optic Nerve
Raff, M. C. (1989) · Science · doi:10.1126/science.2648568 · Cited by 720
Dai, C., Celestino, J. C., Okada, Y., Louis, D. N., Fuller, G. N., & Holland, E. C. (2001) · Genes & Development · doi:10.1101/gad.903001 · Cited by 708
Hermanson, M., Funa, N. S., Hartman, M., Claesson, L., Heldin, C., Westermark, B., & Nistér, M. (1992) · PubMed · Cited by 705
Signalling through phosphoinositide 3-kinases: the lipids take centre stage
Leevers, S. J., Vanhaesebroeck, B., & Waterfield, M. D. (1999) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(99)80029-5 · Cited by 676
Wu, X., Senechal, K., Neshat, M. S., Whang, Y. E., & Sawyers, C. L. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.26.15587 · Cited by 674
Clonal expansion of p53 mutant cells is associated with brain tumour progression
Sidransky, D., Mikkelsen, T., Schwechheimer, K., Rosenblum, M. L., Cavanee, W., & Vogelstein, B. (1992) · Nature · doi:10.1038/355846a0 · Cited by 670
Diversity and frequency of epidermal growth factor receptor mutations in human glioblastomas.
Frederick, L. A., Wang, X. Y., Eley, G. D., & James, C. D. (2000) · PubMed · Cited by 661
Epidermal growth factor receptor and Ink4a/Arf
Bachoo, R. M., Maher, E. A., Ligon, K. L., Sharpless, N. E., Chan, S. S., You, M. J., Tang, Y., DeFrances, J., Stover, E., Weissleder, R., et al. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00046-6 · Cited by 652
Brannan, C. I., Perkins, A. S., Vogel, K. S., Ratner, N., Nordlund, M. L., Reid, S. W., Buchberg, A. M., Jenkins, N. A., Parada, L. F., & Copeland, N. G. (1994) · Genes & Development · doi:10.1101/gad.8.9.1019 · Cited by 641
Self-citationNeurofibromas in NF1: Schwann Cell Origin and Role of Tumor Environment
Zhu, Y., Ghosh, P., Charnay, P., Burns, D. K., & Parada, L. F. (2002) · Science · doi:10.1126/science.1068452 · Cited by 633
Self-citationMechanism-Based Target Identification and Drug Discovery in Cancer Research
Gibbs, J. B. (2000) · Science · doi:10.1126/science.287.5460.1969 · Cited by 606
NF1 Tumor Suppressor Gene Function
Cichowski, K., & Jacks, T. (2001) · Cell · doi:10.1016/s0092-8674(01)00245-8 · Cited by 601
Loss of p16Ink4a confers susceptibility to metastatic melanoma in mice
Krimpenfort, P., Quon, K. C., Mooi, W. J., Loonstra, A., & Berns, A. (2001) · Nature · doi:10.1038/35092584 · Cited by 568 · cited 1×
“cgi?l=12578">Ink4a -homozygous nor Ink4a-heterozygous mice develop astrocytomas, although they are cancer pron”
BackgroundHolland, E. C., Hively, W. P., DePinho, R. A., & Varmus, H. E. (1998) · Genes & Development · doi:10.1101/gad.12.23.3675 · Cited by 556
CDKN2 (p16/MTS1) gene deletion or CDK4 amplification occurs in the majority of glioblastomas.
Schmidt, E., Ichimura, K., Reifenberger, G., & Collins, V. P. (1994) · PubMed · Cited by 508
Oligodendrocyte Population Dynamics and the Role of PDGF In Vivo
Calver, A. R., Hall, A. C., Yu, W.-P., Walsh, F. S., Heath, J. K., Betsholtz, C., & Richardson, W. D. (1998) · Neuron · doi:10.1016/s0896-6273(00)80469-9 · Cited by 501
Guidance of Cell Migration by the Drosophila PDGF/VEGF Receptor
Duchek, P., Somogyi, K., Jékely, G., Beccari, S., & Rørth, P. (2001) · Cell · doi:10.1016/s0092-8674(01)00502-5 · Cited by 475
Mouse Models of Tumor Development in Neurofibromatosis Type 1
Cichowski, K., Shih, T. S., Schmitt, E., Santiago, S., Reilly, K., McLaughlin, M. E., Bronson, R. T., & Jacks, T. (1999) · Science · doi:10.1126/science.286.5447.2172 · Cited by 467
Anticancer drug targets: cell cycle and checkpoint control
Shapiro, G. I., & Harper, J. W. (1999) · Journal of Clinical Investigation · doi:10.1172/jci9054 · Cited by 464
Gliomagenesis: genetic alterations and mouse models
Holland, E. C. (2001) · Nature Reviews Genetics · doi:10.1038/35052535 · Cited by 461
MacDonald, T. J., Brown, K. M., LaFleur, B., Peterson, K., Lawlor, C., Chen, Y., Packer, R. J., Cogen, P., & Stephan, D. A. (2001) · Nature Genetics · doi:10.1038/ng731 · Cited by 455
Defective oligodendrocyte development and severe hypomyelination in PDGF-A knockout mice
Fruttiger, M., Karlsson, L., Hall, A. C., Abramsson, A., Calver, A. R., Boström, H., Willetts, K., Bertold, C.-H., Heath, J. K., Betsholtz, C., et al. (1999) · Development · doi:10.1242/dev.126.3.457 · Cited by 441
Stem cells in the adult mammalian central nervous system
Temple, S., & Alvarez-Buylla, A. (1999) · Current Opinion in Neurobiology · doi:10.1016/s0959-4388(99)80017-8 · Cited by 439
Nf1;Trp53 mutant mice develop glioblastoma with evidence of strain-specific effects
Reilly, K. M., Loisel, D. A., Bronson, R. T., McLaughlin, M. E., & Jacks, T. (2000) · Nature Genetics · doi:10.1038/79075 · Cited by 425
CDKN2/p16 or RB alterations occur in the majority of glioblastomas and are inversely correlated.
Ueki, K., Ono, Y., Henson, J. W., Efird, J. T., von Deimling, A., & Louis, D. N. (1996) · PubMed · Cited by 404
Menon, A. G., Anderson, K. M., Riccardi, V. M., Chung, R. Y., Whaley, J. M., Yandell, D. W., Farmer, G. E., Freiman, R. N., Lee, J. K., & Li, F. P. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.14.5435 · Cited by 395
Legius, E., Marchuk, D. A., Collins, F. S., & Glover, T. W. (1993) · Nature Genetics · doi:10.1038/ng0293-122 · Cited by 391
Mouse Tumor Model for Neurofibromatosis Type 1
Vogel, K. S., Klesse, L. J., Velasco-Miguel, S., Meyers, K., Rushing, E. J., & Parada, L. F. (1999) · Science · doi:10.1126/science.286.5447.2176 · Cited by 372
Self-citationNistér, M., Libermann, T. A., Betsholtz, C., Pettersson, M., Claesson, L., Heldin, C., Schlessinger, J., & Westermark, B. (1988) · PubMed · Cited by 353
Cancer gene therapy: fringe or cutting edge?
McCormick, F. (2001) · Nature Reviews Cancer · doi:10.1038/35101008 · Cited by 346
Proliferation of human malignant astrocytomas is dependent on Ras activation
Guha, A., Feldkamp, M. M., Lau, N., Boss, G., & Pawson, A. (1997) · Oncogene · doi:10.1038/sj.onc.1201455 · Cited by 337
Subsets of Glioblastoma Multiforme Defined by Molecular Genetic Analysis
von Deimling, A., von Ammon, K., Schoenfeld, D., Wiestler, O. D., Seizinger, B. R., & Louis, D. N. (1993) · Brain Pathology · doi:10.1111/j.1750-3639.1993.tb00721.x · Cited by 331
Tyrosine kinase inhibitors: From rational design to clinical trials
Traxler, P., Bold, G., Buchdunger, E., Caravatti, G., Furet, P., Manley, P., O'Reilly, T., Wood, J., & Zimmermann, J. (2001) · Medicinal Research Reviews · doi:10.1002/med.1022 · Cited by 324
Lang, F. F., Miller, D. C., Koslow, M., & Newcomb, E. W. (1994) · Journal of Neurosurgery · doi:10.3171/jns.1994.81.3.0427 · Cited by 300
Guha, A. R., Dashner, K., Black, P. L. M., et al. (1995) · International Journal of Cancer · doi:10.1002/ijc.2910600206 · Cited by 296
Adult Neurogenesis in Mammals: An Identity Crisis
Rakic, P. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-03-00614.2002 · Cited by 295
Side, L., Taylor, B., Cayouette, M., Conner, E., Thompson, P., Luce, M., & Shannon, K. (1997) · New England Journal of Medicine · doi:10.1056/nejm199706123362404 · Cited by 295
p53 mutations are associated with 17p allelic loss in grade II and grade III astrocytoma.
von Deimling, A., Eibl, R. H., Ohgaki, H., Louis, D. N., von Ammon, K., Petersen, I., Kleihues, P., Chung, R. Y., Wiestler, O., & Seizinger, B. R. (1992) · PubMed · Cited by 291
Uhrbom, L., Hesselager, G., Nistér, M., & Westermark, B. (1998) · PubMed · Cited by 283
Simmons, M. L., Lamborn, K. R., Takahashi, M., Chen, P.-Y., Israel, M. A., Berger, M. S., Godfrey, T. E., Nigro, J. M., Prados, M. D., Chang, S. M., et al. (2001) · PubMed · Cited by 278
Ding, H., Roncari, L., Shannon, P. T., Wu, X., Lau, N. C., Karásková, J., Gutmann, D. H., Squire, J. A., Nagy, A., & Guha, A. (2001) · PubMed · Cited by 271
Nielsen, G. P., Stemmer-Rachamimov, A. O., Ino, Y., Møller, M. B., Rosenberg, A. E., & Louis, D. N. (1999) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65507-1 · Cited by 266
Ichimura, K., Schmidt, E., Goike, H., et al. (1996) · PubMed · Cited by 266
Tohma, Y., Gratas, C., Biernat, W., Peraud, A., Fukuda, M., Yonekawa, Y., Kleihues, P., & Ohgaki, H. (1998) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199807000-00005 · Cited by 256
(1997) · PubMed · Cited by 256
Hermanson, M., Funa, K., Koopmann, J., Maintz, D. C., Waha, A., Westermark, B., Heldin, C. H., Wiestler, O. D., Louis, D. N., von Deimling, A., et al. (1996) · PubMed · Cited by 255
Serra, E. (2000) · Human Molecular Genetics · doi:10.1093/hmg/9.20.3055 · Cited by 254
Benign neurofibromas in type 1 neurofibromatosis (NF1) show somatic deletions of the NF1 gene
Colman, S. D., Williams, C. A., & Wallace, M. R. (1995) · Nature Genetics · doi:10.1038/ng0995-90 · Cited by 252
Yamaguchi, F., Saya, H., Bruner, J. M., & Morrison, R. S. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.2.484 · Cited by 245
(1994) · PubMed · Cited by 244
Confirmation of a Double-Hit Model for the NF1Gene in Benign Neurofibromas
Serra, E., Puig, S., Otero, D., Gaona, A., Kruyer, H., Ars, E., Estivill, X., & Lázaro, C. (1997) · The American Journal of Human Genetics · doi:10.1086/515504 · Cited by 242
Pathology of tumors of the peripheral nerve sheath in type 1 neurofibromatosis
Woodruff, J. M. (1999) · American Journal of Medical Genetics · doi:10.1002/(sici)1096-8628(19990326)89:1<23::aid-ajmg6>3.0.co;2-# · Cited by 229
Comparative Study of p53 Gene and Protein Alterations in Human Astrocytic Tumors
Louis, D. N., Deimling, A. V., Chung, R. Y., Rubio, M.-P., Whaley, J. M., Eibl, R. H., Ohgaki, H., Wiestler, O. D., Thor, A. D., & Seizinger, B. R. (1993) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199301000-00005 · Cited by 228
Schlegel, J., Merdes, A., Stumm, G., Albert, F. K., Forsting, M., Hynes, N., & Kiessling, M. (1994) · International Journal of Cancer · doi:10.1002/ijc.2910560114 · Cited by 201
TP53 mutations are frequent in malignant NFI tumors
Legius, E., Dierick, H., Wu, R., Hall, B. K., Marynen, P., Cassiman, J., & Glover, T. W. (1994) · Genes, Chromosomes and Cancer · doi:10.1002/gcc.2870100405 · Cited by 195
Xiao, A., Wu, H., Pandolfi, P. P., Louis, D. N., & Van Dyke, T. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00029-6 · Cited by 188
He, J., Olson, J. J., & James, C. D. (1995) · PubMed · Cited by 188
Ingram, D. A., Yang, F.-C., Travers, J. B., Wenning, M. J., Hiatt, K., New, S., Hood, A., Shannon, K., Williams, D. A., & Clapp, D. W. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.1.181 · Cited by 181
Amplification and Overexpression of MDM2 in Primary (de novo) Glioblastomas
BIERNAT, W., KLEIHUES, P., YONEKAWA, Y., & OHGAKI, H. (1997) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199702000-00009 · Cited by 178
Fulton, B., Burne, J., & Raff, M. (1992) · The Journal of Neuroscience · doi:10.1523/jneurosci.12-12-04816.1992 · Cited by 178
Costello, J., Plass, C., Arap, W., Chapman, V. M., Held, W. A., Berger, M. S., Huang, H., & Cavenee, W. K. (1997) · PubMed · Cited by 173
DeClue, J. E., Heffelfinger, S., Benvenuto, G., Ling, B., Li, S., Rui, W., Vass, W. C., Viskochil, D., & Ratner, N. (2000) · Journal of Clinical Investigation · doi:10.1172/jci7610 · Cited by 172
Takahashi, J. A., Fukumoto, M., Igarashi, K., Oda, Y., Kikuchi, H., & Hatanaka, M. (1992) · Journal of Neurosurgery · doi:10.3171/jns.1992.76.5.0792 · Cited by 171
Kourea, H. P., Orlow, I., Scheithauer, B. W., Cordon-Cardo, C., & Woodruff, J. M. (1999) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65504-6 · Cited by 170
Tumor-selective transgene expression in vivo mediated by an E2F-responsive adenoviral vector
Parr, M. J., Manome, Y., Tanaka, T., Wen, P., Kufe, D. W., Kaelin, W. G., & Fine, H. A. (1997) · Nature Medicine · doi:10.1038/nm1097-1145 · Cited by 169
Lau, N., Feldkamp, M. M., Roncari, L., Loehr, A. H., Shannon, P., Gutmann, D. H., & Guha, A. (2000) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/59.9.759 · Cited by 167
Alterations of cell cycle regulatory genes in primary (de novo) and secondary glioblastomas
Biernat, W., Tohma, Y., Yonekawa, Y., Kleihues, P., & Ohgaki, H. (1997) · Acta Neuropathologica · doi:10.1007/s004010050711 · Cited by 166
Amplification and Expression of Cyclin D Genes (CCND1 CCND2 and CCND3) in Human Malignant Gliomas
Büschges, R., Weber, R. G., Actor, B., Lichter, P., Collins, V. P., & Reifenberger, G. (1999) · Brain Pathology · doi:10.1111/j.1750-3639.1999.tb00532.x · Cited by 164
Loss of NF1 alleles in phaeochromocytomas from patients with type 1 neurofibromatosis
Xu, W., Mulligan, L. M., Ponder, M. A., Liu, L., Ponder, B. A. J., Smith, B. A., & Mathew, C. G. (1992) · Genes Chromosomes and Cancer · doi:10.1002/gcc.2870040411 · Cited by 155
Vogel, K. S., Brannan, C. I., Jenkins, N. A., Copeland, N. G., & Parada, L. F. (1995) · Cell · doi:10.1016/0092-8674(95)90470-0 · Cited by 153
Self-citationKim, H. A., Ling, B., & Ratner, N. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.2.862 · Cited by 152
Sherman, L. S., Atit, R. P., Rosenbaum, T., Cox, A. D., & Ratner, N. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m001702200 · Cited by 151
Fulci, G., Labuhn, M., Maier, D., Lachat, Y., Hausmann, O., Hegi, M. E., Janzer, R. C., Merlo, A., & Van Meir, E. G. (2000) · Oncogene · doi:10.1038/sj.onc.1203700 · Cited by 146
Ingram, D. A., Hiatt, K. K., King, A. J., Fisher, L., Shivakumar, R., Derstine, C., Wenning, M. J., Diaz, B., Travers, J. B., Hood, A. F., et al. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.1.57 · Cited by 134
Kim, H. A., Rosenbaum, T., Ma, M., Ratner, N., & DeClue, J. E. (1995) · PubMed · Cited by 134
Association of EGFR Gene Amplification and CDKN2 (p16/MTS1) Gene Deletion in Glioblastoma Multiforme
Hayashi, Y., Ueki, K., Waha, A., Wiestler, O. D., Louis, D. N., & von Deimling, A. (1997) · Brain Pathology · doi:10.1111/j.1750-3639.1997.tb00890.x · Cited by 128
Molecular Genetic Correlates of p16, cdk4, and pRb Immunohistochemistry in Glioblastomas
Burns, K. L., Ueki, K., Jhung, S., Koh, J., & Louis, D. N. (1998) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199802000-00003 · Cited by 120
Kourea, H. P., Cordon‐Cardo, C., Dudas, M. E., Leung, D. H. Y., & Woodruff, J. M. (1999) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)65508-3 · Cited by 117
Chakravarti, A., Delaney, M. A., Noll, E., Black, P. M., Loeffler, J. S., Muzikansky, A., & Dyson, N. J. (2001) · PubMed · Cited by 111
Nait‐Oumesmar, B., Vignais, L., & Evercooren, A. B. (1997) · Journal of Neuroscience · doi:10.1523/jneurosci.17-01-00125.1997 · Cited by 110
Deletion mapping of the long arm of chromosome 10 in glioblastoma multiforme
Fults, D., & Pedone, C. A. (1993) · Genes Chromosomes and Cancer · doi:10.1002/gcc.2870070311 · Cited by 107
Rasmussen, S. A., Overman, J., Thomson, S. A. M., Colman, S. D., Abernathy, C. R., Trimpert, R. E., Moose, R. E., Virdi, G., Roux, K. J., Bauer, M., et al. (2000) · Genes Chromosomes and Cancer · Cited by 102
Tumorigenic Properties of Neurofibromin-Deficient Neurofibroma Schwann Cells
Muir, D., Neubauer, D., Lim, I. T., Yachnis, A. T., & Wallace, M. R. (2001) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63992-2 · Cited by 102
Yahanda, A. M., Bruner, J. M., Donehower, L. A., & Morrison, R. S. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.8.4249 · Cited by 97
van Meyel, D. J., Ramsay, D. A., Casson, A. G., Keeney, M., Chambers, A. F., & Cairncross, J. G. (1994) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/86.13.1011 · Cited by 96
Neurofibromin, a Tumor Suppressor in the Nervous System
Zhu, Y., & Parada, L. F. (2001) · Experimental Cell Research · doi:10.1006/excr.2000.5138 · Cited by 93
Self-citationOrigin and early development of Schwann cells
Jessen, K. R., & Mirsky, R. (1998) · Microscopy Research and Technique · Cited by 79
Bögler, O., Huang, H.-J. S., & Cavenee, W. K. (1995) · PubMed · Cited by 73
CNTF and its Receptor Subunits in Human Gliomas
Weis, J., Schönrock, L. M., Zuchner, S. L., Lie, D. C., Sure, U., Schul, C., Stögbauer, F., Ringelstein, E. B., & Halfter, H. (1999) · Journal of Neuro-Oncology · doi:10.1023/a:1006303221064 · Cited by 29
Cited by
Applying the principles of stem-cell biology to cancer
Pardal, R., Clarke, M. F., & Morrison, S. J. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1232 · Cited by 1,624
Extensive modulation of a set of microRNAs in primary glioblastoma
Ciafrè, S. A., Galardi, S., Mangiola, A., Ferracin, M., Liu, C.-G., Sabatino, G., Negrini, M., Maira, G., Croce, C. M., & Farace, M. G. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.07.030 · Cited by 1,096
Seoane, J., Le, H.-V., Shen, L., Anderson, S. A., & Massagué, J. (2004) · Cell · doi:10.1016/s0092-8674(04)00298-3 · Cited by 1,028
Isolation of cancer stem cells from adult glioblastoma multiforme
Yuan, X., Curtin, J., Xiong, Y., Liu, G., Waschsmann-Hogiu, S., Farkas, D. L., Black, K. L., & Yu, J. S. (2004) · Oncogene · doi:10.1038/sj.onc.1208311 · Cited by 798
p53 and Pten control neural and glioma stem/progenitor cell renewal and differentiation
Zheng, H., Ying, H., Yan, H., Kimmelman, A. C., Hiller, D. J., Chen, A.-J., Perry, S. R., Tonon, G., Chu, G. C., Ding, Z., et al. (2008) · Nature · doi:10.1038/nature07443 · Cited by 767
Metadata
- Authors
- Zhu, Y., & Parada, L. F.
- Venue
- Nature Reviews Cancer
- Published
- 2002-08-01
- Volume
- 2
- Issue
- 8
- Pages
- 616-626
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W2027185892
- Cited by
- 309
- References
- 132
- FWCI
- 1.60
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.